MedsFacts Meta-Analysis covering adverse side effect reports of BISOCARD (BISOPROLOL) patients who developed URINARY INCONTINENCE.

Introduction: MedsFacts provides MD-approved analysis to help both patients and physicians accurately research and assess the risk-reward trade off for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration, social media, and MedsFacts user submissions. Between January 2004 and October 2012, 1 individuals taking BISOCARD (BISOPROLOL) reported URINARY INCONTINENCE to the FDA. A total of 10 BISOCARD (BISOPROLOL) drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

Topics covered: This page is designed to help you determine the relationship, if any, between BISOCARD (BISOPROLOL) and URINARY INCONTINENCE. In doing so, we compare BISOCARD (BISOPROLOL) with other drugs that cause URINARY INCONTINENCE, to help you evaluate whether or not BISOCARD (BISOPROLOL) causes URINARY INCONTINENCE. Likewise, this page shows the most highly-reported side effects of BISOCARD (BISOPROLOL), so you can see if URINARY INCONTINENCE ranks among BISOCARD (BISOPROLOL)'s most well-known side effects.

The Dashboard explained: The Dashboard first shows general Summary Statistics for BISOCARD (BISOPROLOL) and URINARY INCONTINENCE, such as the raw number and percentage of patients in FDA reports who used BISOCARD (BISOPROLOL) and developed URINARY INCONTINENCE. Next, the Dashboard lists the most common reasons (indications) why BISOCARD (BISOPROLOL) was prescribed for patients. We then display a pie-chart which shows, in aggregate, what we believe represents general physician opinion of the safety of BISOCARD (BISOPROLOL). This pie-chart summarizes, for all FDA reports covering BISOCARD (BISOPROLOL), whether or not the treating physician felt BISOCARD (BISOPROLOL) (versus other drugs the patient was taking) was responsible for the adverse side-effects. After the pie-chart, we itemize the most common side effects in FDA studies covering BISOCARD (BISOPROLOL). You may click on any of these side effects to learn more about them, in general, or specifically for BISOCARD (BISOPROLOL). Finally, we identify the drugs most widely associated with BISOCARD (BISOPROLOL) in FDA literature. You may also click on any of these drugs to view it's dashboard.

Dashboard view of our research literature concerning BISOCARD (BISOPROLOL) :

Summary Statistics
Reports of any side effect of BISOCARD (BISOPROLOL) : 10
Percentage of BISOCARD (BISOPROLOL) patients where URINARY INCONTINENCE is a reported side effect: 10%

FDA reports of any drug causing URINARY INCONTINENCE : 11193
Average percentage for all medicated patients where URINARY INCONTINENCE is reported as a complication: 0.070151116648716%
Most frequent diagnoses/indications for prescribing BISOCARD (BISOPROLOL):
( 0 patients )
Physician opinion on BISOCARD (BISOPROLOL) as adverse event culprit:

(* global)
Twitter feed for BISOCARD (BISOPROLOL) - Pending/Beta

Basic reports are available, free of charge, in PDF format and are suitable for scientific publication. Further data and analytics are available upon request. We are in the process of adding new features to our site, including Q&A interface for patients to speak with experts on medication. Check back with us again in the near future to see.

Copyright 2013 MedsFacts
Privacy Policy
Terms of use